|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 101, 922-925, Copyright © 1992 by American College of Chest Physicians
ARTICLES |
J Kaufman, S Schmitt, J Barnard and W Busse
Medical College of Wisconsin, Milwaukee.
Twenty-one subjects with known bronchial hyperreactivity were prospectively randomized in double-blind fashion to receive one of two angiotensin-converting enzyme inhibitors (ACE-I), enalapril or spirapril, for three weeks. Spirometry and methacholine provocation were performed prior to, during, and following ACE-I usage. Three of 21 subjects developed a nonproductive cough. However, only one subject wheezed slightly. Spirometry and bronchial reactivity (PD20) were unchanged throughout the study.
This article has been cited by other articles:
![]() |
H Lunde, T Hedner, O Samuelsson, J Lotvall, L Andren, L Lindhom, and B E Wilholm Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors BMJ, January 1, 1994; 308(6920): 18 - 18. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |